228 Users Online
Non-opioid Pain Patches Market Segmented By product type such as Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches with distribution channel such as Hospitals, Drug Stores, Retail Pharmacies, Online Pharmacies
Non-opioid pain patches market expected to register significant growth over the forecast period as increasing demand for non- opioid drugs for pain management. Opioid drugs are commonly prescribed for the treatment of pain and related disorders which resulting in dependency of opioid in the majority of patients.
Rising opioid addiction has encouraged to move towards alternative therapies or non-opioid based treatment. Nowadays, Healthcare professionals are inclining towards non-opioid based therapy or drugs as higher awareness among them related to the opioid dependency. Therefore, Non-opioid pain patches expected to gain greater adoption over the opioid patches as the benefits of reduction in opioid addiction.
Growing chronic and acute pain related disorders are driving the growth of the global non-opioid pain patches market. Increasing prevalence of arthritis and post-herpetic neuralgia favor the growth of the global non-opioid pain patches market. According to the Centers for Disease Control and Prevention (CDC), around 15 million people in the United States reported severe joint pain related to arthritis.
The increasing number of sport related injuries, growing number of accident related injuries expected to propel the demand for non-opioid pain patches for pain management. Non-opioid pain patches are also gaining significant demand for surgical pain management as a growing number of surgical procedures globally. Growing demand non-opioid pain patches to reduce addiction related to opioid is a major factor which upsurges the growth of the global non-opioid pain patches market.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
| Based on product type |
|
| Based on indication |
|
| Based on distribution channel |
|
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionSome of the key payers of the non-opioid pain patches market are Pfizer Inc., Teikoku Seiyaku Co. Ltd., GlaxoSmithKline plc., Allergan Plc., Acorda Therapeutics, Inc., Mylan N.V., IBSA Institut Biochimique SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd, Hisamitsu Pharmaceutical Co., Inc., Alkermes plc. and others. Non-opioid pain patches market is a highly fragmented market. Various companies are focusing on the development of the non-opioid pain patches for pain management.
Sales Team
Client Partner
